U.S. FDA approval for sitagliptin base for Zydus Cadilla Arm
Zydus Cadila, one of the leading Indian pharmaceutical companies, announced its tentative approval for its new sitagliptin bases 25, 50 and 100 mg tablets from the United States Food & Drug Administration (FDA). Zydus’ base contains the active moi...
8 September, 2021
Read more